Posts by admin:

Capital Margin Trade Highlights Practical Trading Tools Designed for Structured Market Execution

London, United Kingdom – January 08, 2026 – (SeaPRwire) – Capital Margin Trade has announced a continued focus on strengthening its trading tools, placing practicality ahead of feature volume. The initiative reflects a broader effort to refine how traders interact with the platform on a daily basis, particularly in environments where clarity, timing, and execution discipline tend to outweigh visual appeal or experimental features. The Capital Margin Trade trading platform is built around a straightforward premise. Trading tools should work together smoothly and remain accessible under real market conditions. Market access, charting, and order management are combined within a single interface, reducing the need to switch between sections during active trading. Over time, this type of structure often proves more valuable than frequent interface changes that require constant readjustment. Charting has been one of the more fully formed components of the platform. With multiple chart time frames, layered indicators, and customizable chart layouts, users have an opportunity to evaluate price action without extraneous distractions. The tools continue to remain stable even in times of increased volatility, which is often when stability can become a major issue. While the platform does not aim to replicate institutional-grade software, it offers sufficient analytical depth to support structured technical analysis and routine market monitoring. Execution tools on the Capital Margin Trade broker platform follow a similar logic. Orders can be placed and managed without interrupting the broader workflow, allowing traders to stay focused on market movement rather than interface navigation. Real-time price feeds across supported instruments provide continuous visibility, helping users react as conditions change. Execution speed, as with any platform, remains dependent on market conditions, though overall performance is generally consistent during standard trading hours. Risk management features are integrated directly into the trading process. Users can input a stop-loss and/or take-profit level at the time they enter a trade, or adjust those levels once their trades are active. This provides users with the opportunity to make decisions based upon their own risk assessment without forcing the use of pre-defined automated strategy templates. While some traders may look for deeper automation, others may value the ability to remain closely involved in managing exposure. Beyond execution and charting, the Capital Margin Trade trading platform includes a market overview section that offers context without constant interruptions. Instead of relying on frequent alerts, traders can access summarized information when needed. This quieter approach supports independent analysis and may suit users who prefer to interpret data rather than respond to prompts. Accessibility across devices remains consistent. The Capital Margin Trade broker infrastructure is web-based, allowing traders to access accounts from desktops, laptops, tablets, or smartphones without additional downloads. While mobile trading naturally limits screen space, essential functions such as monitoring positions and placing orders remain available, which can be useful for traders managing positions away from their primary setups. In terms of the way the user interacts with the platform, there are multiple layers of operational complexity. The account settings, margin controls, and view of all open positions are clearly defined and separate from each other, allowing for greater ease of managing exposure to risk without having to navigate through layers of menu options. During active market phases, this clarity can help reduce operational friction. Traders seeking highly customized algorithmic environments may find the setup more manual, though this appears intentional for users who prefer hands-on control. Funding and withdrawal processes follow established industry standards. The platform supports commonly used payment methods and prioritizes reliability over experimentation. While options may seem limited for users seeking alternative payment solutions, transaction procedures remain clear and supported by standard verification processes. Security is treated as a baseline requirement rather than a headline feature. Capital Margin Trade trading platform operations include user verification protocols and encrypted data handling designed to protect account access and transactional information without adding unnecessary complexity to daily use. Overall, the ongoing development of Capital Margin Trade broker services suggests a measured, methodical approach. The emphasis has shifted from seeking rapid expansion and numerous new features every few weeks to maintaining a consistent and reliable trading environment. The steady, long-term nature of this strategy could be attractive to those who have become accustomed to using a platform that they feel comfortable with over time, as opposed to having to adjust to rapidly changing tool behavior and workflow changes at short notice. In addition, for traders who place high value on stability, consistency, and predictability in their trading activities (i.e., those who are able to derive long-term benefits from the familiarity of a consistent trading environment), this long-term approach will likely lead to a more productive long-term trading experience than one based on continuous upgrades. About Capital Margin Trade Capital Margin Trade is an online brokerage firm that provides web-based access to global financial markets, utilizing a web-based trading platform. Capital Margin Trade is focused on providing useful tools to assist traders, along with a stable, functional platform structure that supports traders who take a disciplined, execution-oriented approach to trading versus traders who want to constantly experiment with feature-rich platforms. Media Contact Brand: Capital Margin Trade Contact: Media Relations Team Email: press@capitalmargintrade.com Website: https://capitalmargintrade.com

iMe 与 Attractor:Web3 大规模采用的突破性时刻

香港 - 2026年1月5日 - (SeaPRwire) - Web3 的大规模采用,并不是通过更响亮的叙事或更锋利的口号实现的。它往往是悄然发生的——依托于逐渐隐形的基础设施,在后台无缝支撑人们的日常数字行为。而这一拐点,或许比许多人预期的更近。 iMe 是一款基于 Telegram 的超级应用,融合了即时通讯、AI 交互与去中心化金融(DeFi)。目前,iMe 在 Google Play 和 App Store 的累计下载量已突破 1700 万。其最新发布的 iMe Wallet 2.0 并不仅仅是一次版本升级,而是一次关于 Web3 交付方式的战略性转变。 iMe 并未将加密货币塑造成一种“独立体验”,而是通过 Telegram Mini App(TMA),将 Web3 功能直接嵌入 Telegram。本身。用户无需离开日常使用的聊天界面,就能与数字资产、DeFi 工具以及 AI 辅助工作流进行交互。无需额外下载应用,也无需面对陌生的用户体验,更不会出现刻意的“进入加密世界”的时刻。 在 Telegram 全球用户数逼近 9 亿的背景下,仅这一分发入口本身就代表着一次重大的规模化突破。但真正的关键,在于支撑 iMe 下一阶段增长的底层基础设施。 Attractor:为规模化社区打造的原生 Layer 2 支撑 iMe 扩张的是 Attractor —— 一个正在开发中的区块链项目,致力于构建以 zk-rollup 为核心的 Layer-2 网络,其设计目标并非服务小众的 DeFi 高阶用户,而是面向庞大且高速增长的社区型应用。 与那些主要为单一金融协议优化的通用 Layer-2 不同,Attractor 专为消息、支付、自动化和 AI 交互需要在互联网规模下即时、低成本、无感运行的场景而生。 Attractor 的核心架构特性包括: 零知识 rollup 架构,在保持 Ethereum 级安全性的同时实现高吞吐量 超低交易费用,使面向大众的微交互在经济上可行 支持 Account Abstraction 的设计,消除助记词等使用门槛,实现接近 Web2 的用户体验 原生支持 AI 驱动逻辑,使自动化与 AI agents 能够直接在链上运行 以社区为中心的网络模型,专为服务数百万用户的应用进行优化 在 Layer-2 网络上线后,从 ERC-20 向原生 Attractor 网络无缝迁移的路径 这并不是为投机而打造的基础设施,而是为已经被真实用户使用的产品而构建的。 ATTRA Token 正式上线 Attractor 已完成其原生代币 ATTRA 的 Token Generation Event(TGE)。目前,ATTRA 已作为 ERC-20 资产在去中心化交易所上线。团队已确认,在 Attractor Layer-2 主网上线后,ATTRA 将迁移至原生网络,从而在整个生态系统中释放完整的协议级效用。 这种“先流动性、后基础设施、再生态扩展”的分阶段路径,与迄今为止最成功的 Layer-2 项目高度一致。更重要的是,它将代币价值与真实产品使用深度绑定,而非依赖投机性叙事。 为什么这一时刻至关重要 这是 Web3 发展史上,首次在同一套完整技术栈中同时汇聚三大关键要素: 通过 Telegram 与 iMe 实现的大规模分发 借助 AI 驱动、用户友好交互实现的高度抽象 通过为大众参与而定制的 zk-rollup Layer-2 实现的可扩展性 在这一模式下,用户并不是“进入 Web3”,而是直接使用解决方案。区块链成为看不见的后台,而非用户感知的终点。 如果这一模式成功,iMe 与 Attractor 的协同关系将代表 Web3 增长方式的一次结构性转变:安静、原生、并以互联网规模展开。不是通过教育用户或强迫行为改变,而是通过表面熟悉、底层去中心化的产品自然发生。 这不是渐进式改良,而是那种在历史上往往预示着指数级采用的基础设施级对齐。而如果历史经验仍然适用,最具颠覆性的技术,往往不是最喧哗的——而是那些几乎不被用户察觉的存在。 媒体联系 Email: Info@attra.me Website: www.Attra.Me

iMe 与 Attractor:Web3 大规模采用的突破性时刻

香港 - 2026年1月5日 - (SeaPRwire) - Web3 的大规模采用,并不是通过更响亮的叙事或更锋利的口号实现的。它往往是悄然发生的——依托于逐渐隐形的基础设施,在后台无缝支撑人们的日常数字行为。而这一拐点,或许比许多人预期的更近。 iMe 是一款基于 Telegram 的超级应用,融合了即时通讯、AI 交互与去中心化金融(DeFi)。目前,iMe 在 Google Play 和 App Store 的累计下载量已突破 1700 万。其最新发布的 iMe Wallet 2.0 并不仅仅是一次版本升级,而是一次关于 Web3 交付方式的战略性转变。 iMe 并未将加密货币塑造成一种“独立体验”,而是通过 Telegram Mini App(TMA),将 Web3 功能直接嵌入 Telegram。本身。用户无需离开日常使用的聊天界面,就能与数字资产、DeFi 工具以及 AI 辅助工作流进行交互。无需额外下载应用,也无需面对陌生的用户体验,更不会出现刻意的“进入加密世界”的时刻。 在 Telegram 全球用户数逼近 9 亿的背景下,仅这一分发入口本身就代表着一次重大的规模化突破。但真正的关键,在于支撑 iMe 下一阶段增长的底层基础设施。 Attractor:为规模化社区打造的原生 Layer 2 支撑 iMe 扩张的是 Attractor —— 一个正在开发中的区块链项目,致力于构建以 zk-rollup 为核心的 Layer-2 网络,其设计目标并非服务小众的 DeFi 高阶用户,而是面向庞大且高速增长的社区型应用。 与那些主要为单一金融协议优化的通用 Layer-2 不同,Attractor 专为消息、支付、自动化和 AI 交互需要在互联网规模下即时、低成本、无感运行的场景而生。 Attractor 的核心架构特性包括: 零知识 rollup 架构,在保持 Ethereum 级安全性的同时实现高吞吐量 超低交易费用,使面向大众的微交互在经济上可行 支持 Account Abstraction 的设计,消除助记词等使用门槛,实现接近 Web2 的用户体验 原生支持 AI 驱动逻辑,使自动化与 AI agents 能够直接在链上运行 以社区为中心的网络模型,专为服务数百万用户的应用进行优化 在 Layer-2 网络上线后,从 ERC-20 向原生 Attractor 网络无缝迁移的路径 这并不是为投机而打造的基础设施,而是为已经被真实用户使用的产品而构建的。 ATTRA Token 正式上线 Attractor 已完成其原生代币 ATTRA 的 Token Generation Event(TGE)。目前,ATTRA 已作为 ERC-20 资产在去中心化交易所上线。团队已确认,在 Attractor Layer-2 主网上线后,ATTRA 将迁移至原生网络,从而在整个生态系统中释放完整的协议级效用。 这种“先流动性、后基础设施、再生态扩展”的分阶段路径,与迄今为止最成功的 Layer-2 项目高度一致。更重要的是,它将代币价值与真实产品使用深度绑定,而非依赖投机性叙事。 为什么这一时刻至关重要 这是 Web3 发展史上,首次在同一套完整技术栈中同时汇聚三大关键要素: 通过 Telegram 与 iMe 实现的大规模分发 借助 AI 驱动、用户友好交互实现的高度抽象 通过为大众参与而定制的 zk-rollup Layer-2 实现的可扩展性 在这一模式下,用户并不是“进入 Web3”,而是直接使用解决方案。区块链成为看不见的后台,而非用户感知的终点。 如果这一模式成功,iMe 与 Attractor 的协同关系将代表 Web3 增长方式的一次结构性转变:安静、原生、并以互联网规模展开。不是通过教育用户或强迫行为改变,而是通过表面熟悉、底层去中心化的产品自然发生。 这不是渐进式改良,而是那种在历史上往往预示着指数级采用的基础设施级对齐。而如果历史经验仍然适用,最具颠覆性的技术,往往不是最喧哗的——而是那些几乎不被用户察觉的存在。 媒体联系 Email: Info@attra.me Website: www.Attra.Me

毛绒潮玩开创者「SOFTOPIA超级元气工厂」接连落子国际舞台,诠释品牌出海新路径

引言 2025年第四季度,中国毛绒潮玩品类开创者「SOFTOPIA超级元气工厂」(以下简称SOFTOPIA)在国际化布局上动作频繁,接连亮相高规格文化交流活动并启动长期品牌计划,引发行业关注。作为年度最受瞩目的潮玩品牌,SOFTOPIA于今年上半年获得阅文集团独家战略投资,近期系列动作为其全球化战略落下了实质性注脚。 亮相国际慈善盛典,非遗潮玩首登世界舞台 2025年11月16日,SOFTOPIA作为现场唯一的潮玩品牌,受邀出席于新加坡滨海湾金沙酒店举办的“微博文化交流之夜”。活动聚焦“文化赋能慈善、善意联结民心”,云集了来自文化、艺术、体育及商界的国际嘉宾。 据悉,新加坡政商界高层及内阁官员受邀出席当天晚宴,并与在场的优秀华人企业代表进行了交流。 在此盛会上,SOFTOPIA荣获“微博新加坡年度ESG智造践行企业奖”。同时,品牌携手中国工艺美术大师、国家级非遗代表性传承人,正式发布全球首款非遗毛绒潮玩大娃,标志着中国非遗首次以潮玩为载体登上国际文化交流舞台。 本次活动取得了广泛的传播影响力,相关话题阅读量累计达9.3亿,视频播放量超4100万次,58次登上热搜榜。 受邀非遗推广活动,“了不起的中国潮玩”计划启动 2025年11月24日,由文化和旅游部非物质文化遗产司等单位主办的“非遗品牌推广周”及“千峰互联·搭台引商”非遗品牌资源对接活动在云南大理举行。活动汇聚了中国工商银行、抖音集团、天猫淘宝、腾讯互娱、网易、霸王茶姬等各领域代表性企业。 SOFTOPIA作为潮玩代表品牌参与其中。活动现场,其创始人正式公布“了不起的中国潮玩”长期品牌计划。该计划旨在系统性探索中国非遗与现代潮流的创新融合路径,将传统美学与工艺转化为具有全球吸引力的产品,推动传统文化的当代化表达与传播。 登陆全球顶级游戏渠道,IP商业化获国际认可 在商业拓展方面,SOFTOPIA旗下核心IP“阿豆ADOU”近期作为首个中国潮玩IP,登陆韩国现象级手游《Cookie Run: Kingdom》官方商城,其联名产品已面向全球二十多国的玩家正式发售。 《Cookie Run: Kingdom》由韩国Devsisters开发,自2021年上线以来于全球市场表现强劲。据第三方机构Sensor Tower数据显示,该游戏在2025年2月位列全球手游收入增长榜前列。 此前,其联名对象均为迪士尼、防弹少年团(BTS)等国际顶级IP与艺人。 此次成功入驻,意味着中国原创潮玩IP首次通过全球头部商业平台,直接触达海外庞大玩家社群,实现品牌从文化亮相到商业兑现的关键一跃。 结语:稳健拓展全球化版图 从开创毛绒潮玩品类市场,到获得战略投资深化IP生态,直至近期在国际文化舞台与全球商业渠道的同步推进,SOFTOPIA展现出清晰而稳健的全球化路径。通过产品创新、文化赋能与商业合作的多维布局,品牌正逐步在竞争激烈的全球潮玩市场中,构筑起坚实的差异化竞争优势。

Plush Art Toy Pioneer SOFTOPIA Makes Strategic Moves on Global Stage, Charting a New Course for Brand Globalization

Introduction In the fourth quarter of 2025, SOFTOPIA, the pioneer of the plush art toy category in China, accelerated its global footprint with a series of high-profile appearances at cultural exchanges and the launch of a long-term brand initiative. As one of the year's most watched brands in the sector, SOFTOPIA, which secured exclusive strategic investment from China Literature Limited‌ earlier this year, is now putting its global strategy into substantive action. Spotlight at International Gala: Intangible Cultural Heritage Plush Collectible Debuts on World Stage  On November 16, 2025, SOFTOPIA attended the “Weibo Cultural Exchange Gala” at Singapore's Marina Bay Sands as the sole art toy brand present. The gala, centered on the theme “Empowering Charity through Culture, Connecting People through Kindness,” brought together international guests from cultural, artistic, athletic, and business circles. Senior officials from Singapore's government and business community were also in attendance, engaging with leading Chinese enterprise representatives. At the event, SOFTOPIA was honored with the Weibo Singapore Award for Sustainable and Intelligent Manufacturing. In collaboration with a Chinese Master of Arts and Crafts and a national intangible cultural heritage (ICH) representative inheritor, the brand unveiled the world's first ICH-themed plush art collectible. This debut marks the first time Chinese ICH has been presented on an international cultural exchange platform through the medium of art toys. The gala achieved significant digital traction, with related topics garnering 930 million reads, video playbacks exceeding 41 million, and making 58 appearances on hot search lists. Featured at National ICH Forum: “The Great Chinese Art Toys” Unveiled  On November 24, 2025, the “Intangible Cultural Heritage Brand Promotion Week” and the forum “Bridging Peaks & Businesses: A Resource Linkage Forum,” organized by the Ministry of Culture and Tourism's Intangible Cultural Heritage Department, were held in Dali, Yunnan. The event convened representatives from across industries, including the Industrial and Commercial Bank of China (ICBC), ByteDance (operator of Douyin), Alibaba Group's Tmall Taobao, Tencent Interactive Entertainment, NetEase, and CHAGEE. Participating as a representative art toy brand, SOFTOPIA’s founder unveiled the long-term brand initiative: “The Great Chinese Art Toys.” This initiative aims to systematically explore innovative avenues for integrating China's ICH with contemporary trends, transforming traditional aesthetics and craftsmanship into products with global appeal, thereby promoting the modern expression and dissemination of traditional culture. Accessing Top-Tier Global Platform: Flagship IP Gains International Commercial Recognition In a key business development, SOFTOPIA's flagship IP “ADOU” recently became the first Chinese art toy IP to launch collaborative products in the official store of the South Korean hit mobile game Cookie Run: Kingdom. The merchandise is now available to players in over twenty countries worldwide. Developed by Devsisters, Cookie Run: Kingdom has shown robust global performance since its 2021 launch. According to data from third-party analytics firm Sensor Tower, the game ranked among the top performers in worldwide mobile game revenue growth in February 2025. Its previous collaboration partners have been international top-tier IPs and artists like Disney and BTS. This successful entry represents a pivotal leap for an original Chinese art toy IP, enabling it to directly reach a vast overseas player community through a leading global commercial platform, thus transitioning from cultural visibility to tangible commercial success. Conclusion: Steadily Expanding a Global Blueprint  From defining the plush art toy market to deepening its IP ecosystem with strategic investment, and now to advancing simultaneously on international cultural and commercial fronts, SOFTOPIA demonstrates a clear and steady globalization path. Through its multidimensional strategy encompassing product innovation, cultural empowerment, and strategic partnerships, the brand is progressively forging a distinctive competitive edge in the intense global art toy market.

Taxinexo Advances Large-Scale Commercial Deployment of Level 4 Autonomous Vehicles Across the United States

New York, NY – December 26, 2025 – (SeaPRwire) – Taxinexo, a U.S.-based autonomous vehicle operator, has entered a new phase of large-scale commercial deployment after nearly five years of continuous operation in the United States. Leveraging its mature Level 4 autonomous driving technology and proven operational capabilities, the company has expanded multi-scenario services across several U.S. states, positioning itself as a representative case of how federal and state policy coordination is accelerating the commercialization of autonomous driving in the U.S. smart mobility sector. Since its inception, Taxinexo’s growth trajectory has been deeply intertwined with the US autonomous driving industry’s policy support system. The US federal government, through national strategic documents such as the Comprehensive Autonomous Vehicle Initiative, has established a development orientation of “safety first, encouraging innovation,” providing companies with a flexible regulatory environment—including simplified administrative exemption procedures for autonomous vehicles, allowing steering wheel-less and pedal-less vehicles that meet technical standards to be tested and operated on public roads, significantly lowering the policy threshold for companies to iterate their technology. Meanwhile, the Inflation Reduction Act’s tax credit of up to $7,500 per vehicle for Level 3 and above autonomous driving vehicles further assisted Taxinexo in completing its R&D investment and fleet expansion, enabling it to achieve large-scale commercial operation in multiple states across the US. This has allowed it to accumulate millions of kilometers of real-world road operation data and build an operational network covering diverse scenarios such as urban main roads, business parks, and commuter shuttles. In an interview with this newspaper, Taxinexo’s Global Marketing Head stated, “The policy support in the US over the past five years has provided us with an excellent development platform. From technology R&D to commercialization, the flexible regulatory environment and precise policy support have allowed us to accumulate core capabilities to handle complex scenarios. In the future, we will continue to leverage local policy advantages, deepen our diversified scenario operation layout, and help promote the US autonomous driving industry towards a more efficient and safer stage.” Data shows that the US autonomous driving industry is rapidly expanding, with leading companies continuously increasing their fleet sizes and weekly order volume exceeding hundreds of thousands, indicating a broad commercial prospect for the industry. Taxinexo reportedly plans to further expand its service coverage in the United States based on its existing operations, focusing on high-frequency travel scenarios such as airport shuttles and intercity commuting, and will continue to increase investment in technology research and development to promote the iterative upgrade of its autonomous driving system. In the future, its large-scale operational experience may provide a replicable practice model for the intelligent transportation upgrades of more cities in the United States. Social Links Telegram: https://t.me/taxinexo X: https://x.com/taxinexo Facebook: https://www.facebook.com/profile.php?id=61585301312596 Instagram: https://www.instagram.com/taxinexo LinkedIn: https://www.linkedin.com/company/taxinexo/ YouTube: https://www.youtube.com/@taxinexo Media contact Brand: Taxinexo Contact: Media team Email: support@taxinexo.com Website: https://www.taxinexo.com

Wuliangye's Influencer Dining in Singapore: A Symphony of Nanyang Charm and Rich National Fragrance

On December 3 local time, an influencer dining that fused a millennium of Eastern baijiu-making wisdom with the exquisite culinary aesthetics of Southeast Asia elegantly kicked off at the Michelin-starred restaurant Seroja in Singapore. As the global partner of the Michelin Guide in China, Wuliangye collaborated with Chef Kevin Wong of Seroja, as well as Thevar and its Chef Mano Thevar, to create a sensory feast that transcended taste boundaries and intertwined cultural threads. Craftsmanship Meets Flavor: Exploring Fusion Realms During the influencer dining, representatives from Wuliangye delved into the brand's profound historical roots and introduced guests to how the brand connects with global culinary trends. Originating from Yibin, Sichuan, Wuliangye is built upon the unique baijiu-making ecosystem formed by ancient fermentation pits from the Yuan Dynasty and harmoniously brews five types of grains, embodying its baijiu-making philosophy of "Diversified Harmony". From this foundation, Wuliangye sees itself as a bridge connecting Eastern and Western culinary arts, committed to fostering a dialogue between traditional baijiu-making wisdom and contemporary culinary creativity. Chef Kevin Wong of Seroja drew inspiration from the Malay archipelago, transforming the essence of Southeast Asian culinary culture into refined dishes that embody both locality and international flair. Meanwhile, the guest restaurant Thevar reinterprets Indian flavors with modern techniques, showcasing a contemporary dining language filled with rich layers of spices. The collaboration between Wuliangye and these two distinctly styled and deeply rooted restaurants vividly reflects the brand's inclusivity and creativity inherent in its "Diversified Harmony" philosophy. Chinese Baijiu as a Cultural Resonance on Nanyang Tables During the event, renowned Southeast Asian sommelier Sidney Tan provided guests with a systematic explanation and demonstration of the "Wuliangye Five-Step Tasting Ritual." Guiding guests through a scientific and poetic approach, she invited them to appreciate the multiple layers of aroma—such as aged fragrance, fermentation pits aroma, grain scent, and fruity notes—contained within Wuliangye. At the same time, the chefs of Seroja and Thevar jointly designed a tasting menu that combined the culinary cultures of both regions. They creatively paired dishes—Seroja’s island-fresh cuisine with Thevar's Indian-spice dishes—achieving precise flavor resonance with Wuliangye’s offerings. Guests experienced a perfect symphony between Wuliangye and diverse dishes, noting that "its abundant aromas not only enhanced the natural flavors of the ingredients but also elevated the complexity of fresh and spice notes, achieving a sublime and extended flavor experience." Attendees at the Singapore influencer dining remarked, "It's delightful to see Chinese flavors integrated into global cuisine in such a way. I'm pleasantly surprised to savor this creative and harmonious pairing of food and baijiu." From Experimental Spaces to Everyday Settings: Deep Transformation of Food and Baijiu Fusion Concepts Wuliangye and Michelin Guide successfully co-hosted a influencer dining is not only a source of inspiration but also a profound experiment and validation of the fusion of food and baijiu concepts. Insights gained from these high-profile occasions are continually injected into broader dining practices. As an important overseas establishment, Wuliangye Dining Singapore plays a crucial role as a "daily experience window." Since its establishment in September 2025 in the Bugis culinary hotspot, its new Chinese-style space and Cantonese fusion cuisine have become a landmark destination for local diners to experience the aesthetics of Chinese cuisine. Executive Chef Alex Chen, after participating in the influencer dining, expressed, "The collision of global cuisine with Wuliangye sparks infinite possibilities. The rich flavor structure of Wuliangye allows us to break through traditional frameworks and create numerous innovative pairings that encompass color, aroma, flavor, and quality." Inspiration drawn from this Wuliangye Dining Singapore has already transformed into tangible experiences on the restaurant’s menu. For example, a classic Cantonese barbecue dish could be reinvigorated by pairing it with a specific vintage of Wuliangye, where the Baijiu's smooth sweetness and fruitiness perfectly balance the richness of the meat, illustrating an Eastern aesthetic distinct from baijiu pairings. Taste Without Borders: Building a New Chapter in International Narratives In recent years, Wuliangye has systematically constructed a brand narrative system for global high-end culinary consumption through deep collaborations with international authoritative dining guides, top restaurants, and avant-garde chefs. The hosting of this influencer dining in Singapore not only represents a cross-border dialogue of tastes but also serves as a vivid practice of Wuliangye's integration into local culture, engaging in multi-dimensional interactions with local culinary philosophies and baijiu-making techniques. From a strategic perspective, Wuliangye Dining Singapore, alongside the Michelin-starred dining, constructs a multi-faceted, coordinated brand communication ecosystem. Influencer dining act as "quality lighthouses," striving to explore the boundaries of flavor and define the heights of pairing, attracting the attention of the global culinary community. Meanwhile, the restaurant serves as a "foundation of experience," transforming cutting-edge concepts of food and baijiu pairing into an everyday taste journey, deeply cultivating consumer perceptions and drinking habits. This blend of "top-tier leadership" and "everyday nourishment" not only deepens Wuliangye's "Diversified Harmony" brand philosophy but also provides an innovative pathway for the internationalization of Chinese baijiu, from concepts to market and from scenarios to life.

THE HANEDA GODZILLA GLOBAL PROJECT OFFICIALLY KICKS OFF COMPLETION EVENT

The King of the Monsters Becomes a Cinematic Welcome and Farewell, Showcasing Japanese Entertainment to Millions of International Travelers at Japan’s Global Gateway Singapore – December 23, 2025 – (SeaPRwire) – The HANEDA GODZILLA GLOBAL PROJECT officially launched a mega-scale initiative to broadcast Japanese entertainment to the world from Haneda Airport, through the collaboration of three companies: Toho Co., Ltd., Japan Airport Terminal Co., Ltd., and Tokyo International Airport Terminal Corporation. Under the theme “Godzilla welcomes all visitors to Japan and sees them off as they depart,” a colossal Godzilla statue, approximately 40 meters long and 9 meters tall, has been revealed inside Japan’s international gateway at Haneda Airport Terminal 3. Modeled after the original Godzilla, the monument surpasses the size of existing indoor installations and is designed to be viewed from multiple angles throughout Terminal 3. Additional installations in the area include Godzilla: The Great Monster Advance Picture Scroll in the arrival lobby and a standing statue from Godzilla Minus One that will be installed on December 3, further expanding the presence of the popular monster across arrivals and departures. To commemorate the completion of the world’s largest indoor Godzilla monument, a special announcement event was held at Haneda Airport, featuring remarks from notable guests. This consisted of Keiji Ota, Senior Managing Executive Officer and Chief Godzilla Officer (CGO) of Toho Co., Ltd.; Masatoshi Akahori, President and Representative Director of Tokyo International Air Terminal Corporation; and special guest actress Riko Fukumoto, ambassador for the “Godzilla The Ride” attraction at Seibuen Amusement Park. All of the guest speakers reflected on the cultural significance of the six-year project and Godzilla’s role as a global symbol of Japanese entertainment. As travel ramps up for the new year, the HANEDA GODZILLA GLOBAL PROJECT is set to leave a lasting impression on millions of international travelers passing through Terminal 3 with an encounter with one of Japan’s most iconic cultural symbols. The completion announcement event was held on Friday, December 19, with public installations opening in conjunction with year-end and New Year travel, and additional displays debuting beginning December 23. The unveiling was held at Haneda Airport Terminal 3 in Tokyo, Japan spanning both the departure and arrival lobbies at Japan’s primary international gateway. About TOHO Co., Ltd. TOHO Co., Ltd. is a leading Japanese entertainment company founded in 1932.  Its four main business pillars are the cinema business, which includes production, distribution and exhibition; the theatrical business, which includes production and exhibition; the anime business, which has been expanding globally in recent years; and the real estate business, which focuses on development in urban areas. TOHO’s worldwide acclaimed works include theatrical films such as the “Godzilla” series and “Seven Samurai” directed by Akira Kurosawa, and TV anime series such as “My Hero Academia” and “Jujutsu Kaisen”. These anime series are produced and distributed through the TOHO animation label, and are delivered to a wide range of audiences around the world. Media Contact TOHO Entertainment Asia hello@tohoea.com.sg

Holiverse Announces Development of Offline AI Device to Return Data Control to Users

New York, NY – December 23, 2025 – (SeaPRwire) – Holiverse, a biotech platform, has begun active development of a decentralized AI device designed to operate entirely offline without cloud dependency. The device will embed private artificial intelligence directly on hardware, eliminating the need to transmit personal data to external servers. According to the company, this approach addresses growing concerns about data sovereignty, privacy erosion and the concentration of AI processing power in centralized platforms. “We have conflated intelligence with centralization,” said Lado Okhotnikov, founder of Holiverse. “We built these vast, brilliant minds and asked them to solve our problems. But in doing so, we outsourced our sovereignty.” The Holiverse decentralized AI initiative targets three key capabilities: On-device processing: All data remains in a closed loop on the user’s hardware Offline functionality: Intelligence operates without internet connectivity Hyper-personalization: Models tuned to individual biological and behavioral data “This is undoubtedly a complex and resource-intensive process, and we are engaging some of the leading AI specialists,” Okhotnikov added. “This technology has the potential to significantly reduce the risks associated with AI and make interaction with it truly personal.” Holiverse expects to present initial developments publicly in the coming months. About Holiverse Holiverse is a biotech platform that integrates human biology and advanced technology. Founded by Lado Okhotnikov, the company creates holistic health solutions through personalized, data-driven approaches. Learn more at holiverse.ai. Social Links X: https://x.com/Holiverse Telegram: https://t.me/holiverse_ENG Media Contact Brand: Holiverse Contact: Media team Email: mailbox@holiverse.ai Website: https://holiverse.ai

HTM Korea Launches Advanced CERA+ Fire Suppression Patch, Expanding Global Safety Solutions

Seoul, Korea – December 23, 2025 – (SeaPRwire) – HTM Korea, a Korean fire-safety technology company, announced the global expansion of its innovative automatic fire-suppression product line, CERA+, designed to prevent electrical fires in outlets and distribution boards. The company has rapidly grown within the domestic market through public procurement channels, supplying products to government agencies, educational institutions, and major industrial clients. CERA+ is a compact fire-suppression patch that activates automatically when an electrical hotspot occurs. Containing a certified clean-agent extinguishing compound, the patch bursts at a specific temperature and releases the agent to suppress flames at the earliest stage. The product has received official KFI (Korea Fire Institute) type approval, along with reliability tests such as temperature, humidity, and durability evaluations. HTM Korea currently offers outlet-type patches and distribution-board models in 20L, 40L, and 80L capacities. The company is accelerating its entry into Southeast Asia, the Middle East, and the United States, supported by growing demand from data centers, residential complexes, and industrial facilities. “As electrical fire risks continue to rise worldwide, we aim to provide simple but highly effective protection that any facility can adopt easily,” said a company representative. “We will continue expanding our product line and strengthening global partnerships.” Media contact Company: HTM Korea Co., Ltd. Contact: Su Hyeon Oh Phone: +82-10-3504-2913 Email: cera@cera.krWebsite: https://www.cera.kr

The Third Market Opens Korea’s First Experiential Refurbished Electronics Showroom

Seoul, Korea – December 23, 2025 – (SeaPRwire) – The Third Market Co., Ltd. has opened Korea’s first Experiential Refurbished Electronics Showroom, a space where customers can directly test, compare, and verify refurbished electronics with full transparency. The showroom was created to solve long-standing consumer concerns around inconsistent quality and unclear product history in the refurb market. The Third Market manages the entire process in-house, including inspection, grading, labeling, and warranty issuance. Visitors can observe real-time inspection, review visualized product reports, and experience devices firsthand—shifting refurbished products from “low-cost alternatives” to “value-verified choices.” The showroom integrates an inspection center, exhibition zone, and logistics area, enabling seamless processing from intake to purchase. With its internal branding and design team, Third Market provides standardized labels, branded packaging, and expert consultations to enhance consumer trust. A dedicated Small Business Pop-Up Zone also supports local merchants by offering a new retail channel for overstock and returned goods, contributing to a healthier refurb ecosystem. “Our goal is to establish a new standard of trust in refurbished electronics,” said CEO Sang-ho Yoo. “Customers should be able to see exactly how products are evaluated and feel confident in their value.” The Third Market plans to expand additional hubs, enhance automated inspection technology, and strengthen global partnerships as it shapes the future of the refurbished electronics market. Media contact Brand: The Third Market Contact: Sang-ho Yoo Phone: +821041143582 Email: biz@ttm.imWebsite: https://shop.ttm.im

Asia Pricing Professionals Launches Major 2026 Expansion with Global Certification Partnership and Two Flagship Conferences in Singapore

Singapore – December 22, 2025 – (SeaPRwire) – Asia Pricing Professionals (APP), the leading pricing and commercial excellence community in Asia-Pacific, today announced a major expansion of its professional development, certification, and community platform for 2026. The expanded portfolio positions APP as the region’s most comprehensive ecosystem for pricing, value management, and revenue excellence. Central to the 2026 expansion is a strategic partnership with the Professional Pricing Society (PPS), connecting global best practices with regional execution to support individuals, teams, and organizations as pricing evolves into a strategic, AI-enabled business capability. Comprehensive Pricing Training & Global Certifications From 2026, APP members will gain access to 100+ on-demand pricing courses through its collaboration with PPS, covering the full pricing and monetization lifecycle — from foundational principles to advanced real-world application. The curriculum spans: Pricing strategy and value creation Pricing analytics and data-driven decision-making Execution, governance, and price realization Negotiation and deal pricing SaaS and XaaS monetization models AI-enabled pricing and advanced analytics Organizational design and change management In addition, APP will offer globally recognized certifications, including the Certified Pricing Professional (CPP®) designation — the only worldwide credential synthesizing the art and science of pricing — and a new AI Pricing Certification, designed to help professionals apply artificial intelligence responsibly and effectively in pricing, forecasting, and commercial decision-making. Two Flagship APP Conferences in Singapore (2026) As part of its expanded offering, APP will host two one-day flagship conferences in Singapore in 2026, bringing together senior pricing, commercial, and revenue leaders from across Asia-Pacific. APP Conference 1 5 March 2026 | Singapore Theme: Smart Value: AI and the Future of Pricing & Revenue Growth The conference will explore how AI, analytics, and advanced pricing capabilities are transforming value creation, pricing decisions, and sustainable revenue growth. Key topics include AI-driven pricing, predictive analytics, price corridors, deal pricing, execution excellence, and ethics and governance in AI-enabled pricing. APP Conference 2 15 October 2026 | Singapore Theme: Total Revenue Excellence: Integrating Pricing, Profitability & Commercial Performance This event will focus on breaking organizational silos between Pricing, Sales, Finance, Revenue Management, and Commercial Operations to drive end-to-end revenue and profit performance. Key topics include deal desk design, discount discipline, KPI alignment, commercial operating models, and scaling revenue excellence across regions. Face-to-Face Training & Regional Networking Immediately following each conference, APP will deliver in-person, instructor-led training programs in Singapore on 6 March and 16 October 2026. These hands-on sessions focus on applied execution and advanced case work, and both count toward CPP® certification credits. In the second half of 2026, APP will also launch its “Five Big Cities” Networking Tour, with events planned in: Bangkok Jakarta Manila Shanghai Singapore Each event will feature curated networking, practitioner roundtables, and thought leadership discussions, strengthening APP’s role as a regional connector between local markets and global best practices. An Integrated Pricing Ecosystem for Asia-Pacific Together, APP’s training, certifications, conferences, live programs, and regional networking form a single integrated ecosystem designed to: Build pricing and commercial capability at scale Bridge theory with real-world execution Support career progression and organizational maturity Advance ethical, data-driven, and AI-enabled pricing across Asia-Pacific About Asia Pricing Professionals (APP) Founded in 2010, Asia Pricing Professionals is a not-for-profit community dedicated to advancing pricing, value management, and commercial excellence across Asia-Pacific. APP connects practitioners, leaders, and organizations through education, certification, events, and peer collaboration. Social Links LinkedIn: https://www.linkedin.com/groups/3813123/ Instagram: https://www.instagram.com/asiapricingprofessionals Media contact Brand: Asia Pricing Professionals Contact: Media team Email: deepaksood@asiapricingprofessionals.org Website: https://asiapricingprofessionals.org

CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China

SHENZHEN, Dec 15, 2025 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for an independent listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of the Company dated 22 April 2025 for details), has obtained the relevant licensing rights to the innovative oral JAK1 inhibitor povorcitinib (proposed English generic name: Povorcitinib Phosphate Tablets) (“povorcitinib” or the “Product”), which has been included in the list of Breakthrough Therapeutic Drugs by the Center for Drug Evaluation of the National Medical Products Administration of the People’s Republic of China (“NMPA”), with a proposed indication for adult patients with non-segmental vitiligo. This certification has the potential to accelerate the development and review process of the Product. Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for non-segmental vitiligo, moderate to severe hidradenitis suppurativa (HS) and prurigo nodularis in several countries outside China. A Phase 2 clinical trial for the treatment of asthma is also ongoing. In March 2023, Incyte announced that povorcitinib met the primary endpoint in a global multi-center Phase 2b clinical trial for non-segmental vitiligo. Results showed that after 24 weeks of treatment, compared with vehicle, total body repigmentation of patients treated with povorcitinib once daily was significantly improved. Furthermore, according to the extended Phase 2b trial, longer-term use of povorcitinib demonstrated further improvement in total body and facial repigmentation with a favorable tolerability profile[1].  In August 2025, Dermavon received the drug clinical trial approval notice issued by NMPA to conduct clinical trials of povorcitinib for the treatment of non-segmental vitiligo and other indications. Dermavon has initiated the clinical development of the Product in China and may consider further initiating clinical development of povorcitinib in China for the treatment of skin-related diseases such as HS and prurigo nodularis in the future. Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[2]. Currently, therapeutic options for vitiligo are limited, and the condition is difficult to treat, especially for patients with moderate to severe extensive vitiligo. If approved in China, povorcitinib could provide a differentiated treatment option for patients with non-segmental vitiligo. The Product’s inclusion in the list of Breakthrough Therapeutic Drugs is expected to accelerate its development and review process in mainland China. If approved for marketing in China, the Product has the potential to synergize with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream) and the innovative drug currently under New Drug Application (NDA) review ruxolitinib phosphate cream, helping the product to quickly realize its clinical and commercial value and benefit more patients with skin diseases. Furthermore, if approved, the Product, together with topical ruxolitinib phosphate cream, will provide vitiligo patients with differentiated and comprehensive treatment options. The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement (the “License Agreement”) for povorcitinib on 31 March 2024 with Incyte, obtaining an exclusive license to research, develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights of povorcitinib in the Territory other than Mainland China to the Group (excluding Dermavon and its subsidiaries). About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.  Reference: 1. Results from a global multi-center Phase 2b clinical trial of the product for non-segmental vitiligo indication can be found on the Incyte official website: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-data-phase-2b-study-evaluating-povorcitinib 2. Datas are from the China Insights Consultancy (CIC) report CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/

Solving the 'Invisible Asset' Crisis: Why one company’s Whisky Storage Model is 90% Subscribed

Singapore - December 12, 2025 - (SeaPRwire) - In a clear signal of the city-state's booming alternative asset market, Whisky Mansion, a boutique storage facility housed in a heritage shophouse at Boat Quay, reported this week that its specialized vaults reached 90% capacity just four months after launch. This rapid uptake highlights a shift in how local investors manage their "liquid portfolios." No longer content with remote industrial warehouses, Singapore’s collectors are increasingly demanding accessible, luxury storage within the Central Business District. Solving the 'Invisible Asset' Problem Historically, alcohol storage in Singapore has been utilitarian. Malcolm De Silva, Managing Director of Rare & Refine Pte Ltd, argues this model creates a liquidity trap. "The fundamental question every investor faces is: 'How does a collector sell his whisky when nobody sees it?'" said De Silva. "By turning our vault into a visible gallery, the collection remains 'alive' and showcase-ready." To further solve this, Whisky Mansion has introduced a dedicated app allowing members to value, curate, and manage their collections digitally, ensuring assets are as visible on screen as they are in the vault. A Community for the Rarest Whiskies The venue's appeal lies in its "Clubhouse" model. Whisky enthusiasts have flocked to the venue to view some of the rarest whiskies in the world and immerse themselves in a space where like-minded collectors gather. The ecosystem features 'Curo,' a casual dining restaurant, and 'Curo Reserve,' a private members' club. Dedicated event rooms allow members to host masterclasses alongside their stored collections. "It turns storage into an experience," De Silva added. "It is a home for the community, not just a warehouse for bottles." Future Expansion: Wine & Watches Demand for this luxury model is spilling over into other asset classes. Management reports a wave of inquiries from wine and watch enthusiasts seeking similar secure, climate-controlled environments. With the current vault nearing capacity, Whisky Mansion confirmed plans to expand its boutique footprint to accommodate the growing waitlist. Visit for more information www.whiskymansion.com For Press contacts, contact Dani – enquiries@whiskymansion.com

Global Leadership Redefined: Andy Lin, Violist and Erhu Virtuoso, Unveils Vision for International Arts Academy in Asia

Dec. 11, 2025 - (SeaPRwire) - According to a report published by "The Icons", highly accomplished violist and Erhu Virtuoso Andy Lin successfully redefined the traditional image of leadership during his tenure as President of the World Taiwanese Chambers of Commerce – Junior Chapter (WTCCJC). By leveraging his unique blend of cultural artistry and human warmth, Lin injected a dynamic new spirit and connectivity into the international organization, and has now announced his next major endeavor: establishing a pioneering international academy of performing arts in Asia. Unlike previous WTCCJC presidents, who often came from established corporate backgrounds, Lin, a musician with a Doctor of Musical Arts degree, chose a distinctly different path. He emphasized that his approach was not dictated by titles or authority, but by treating every member with "artistic sensitivity and human warmth." Lin described his leadership style as akin to performing "chamber music," promoting coordination and collective decision-making over command and control, stating that true harmony arises from finding balance among diverse voices rather than relying on the loudest voice. Throughout his presidency, Lin traveled tirelessly across six continents, attending over thirty conferences and community events. Through impromptu musical performances and genuine one-on-one dialogue, he transformed WTCCJC into a comprehensive platform for cross-cultural exchange. Lin noted that this dedication to human connection and cultural engagement yielded the most fulfilling results, effectively turning a traditionally rule-bound organization into a bridge for shared vision and trust across continents. A significant outcome of his tenure was the creation and performance of "The Song of WTCCJC." This original composition quickly became a powerful, unifying symbol for the organization, with its opening line, "When stars gather from every corner of the world," serving as an emotional anchor for global members. Lin stressed that culture is a form of governance that unites people through shared emotions and symbols, making cross-continental collaboration effortless and leading to tangible results, such as connecting premium Vietnamese coffee to the New York market and supporting a Japanese medical-aesthetics brand's entry into the U.S. healthcare system. Following his successful term, Lin has shifted his focus to a new, major cultural initiative: establishing a world-class performing arts academy in Taiwan. This institution is planned to transcend conventional boundaries, integrating music, theatre, dance, interdisciplinary creation, and cultural technology. Lin's vision is to nurture creativity and cultural dialogue, making the academy a destination for global artists and effectively positioning Asia as a future center for the performing arts. He firmly believes that the school will become a meeting point for young artists from every nation, who will become "carriers of culture, taking Taiwan's stories back to the world—and bringing the world's colors into Taiwan." This culture-driven leadership model is set to continue its profound influence on the next generation of global leaders.

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

SHENZHEN, Dec 11, 2025 – (ACN Newswire) – China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) (“Y-3 for Injection” or the “Product”) has been accepted by National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a brain cytoprotectant indicated for the treatment of acute ischemic stroke. With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important targets PSD95-nNOS and MPO, in the pathological processes of stroke, Y-3 for Injection acts on multiple key pathological processes of the ischemic cascade in ischemic stroke. Through multi-target, highly selective synergy, it is more conducive to exerting brain cytoprotective effects. The Product has an excellent therapeutic effect on ischemic stroke and the potential to prevent post-stroke depression and anxiety symptoms. Y-3 for Injection demonstrates excellent clinical data with excellent efficacy and a favorable safety profile. The results of Phase II clinical trial of the Product in China indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (40mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group, with a rate difference of 16%. The Phase III clinical trial of the Product in China was conducted by Beijing Tiantan Hospital, Capital Medical University as the leading site. It has enrolled nearly 1,000 patients with acute ischemic stroke within 48 hours of onset across approximately 40 research centers nationwide, aiming to evaluate the efficacy and safety of Y-3 for Injection in treating patients with acute ischemic stroke within 48 hours of onset. The Phase III clinical study met the primary efficacy endpoint, with patients achieving significant clinical benefits and an overall favorable safety profile. The key study results are planned to be presented at international academic conferences, and the full study will be published in international academic journals. The Central Nervous System (CNS) is one of the core advantageous fields of CMS, where a deeply integrated layout has been progressively established. The product portfolio has solidified the market foundation, including the marketed innovative drug VALTOCO (Diazepam Nasal Spray), the original brand drug Deanxit (Flupentixol and Melitracen Tablets), and the improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets), which is currently under NDA review. The addition of Y-3 for Injection will further strengthen the product portfolio, generating highly efficient synergies in terms of expert networks and market resources. It is expected that if approved for marketing, Y-3 for Injection will bring a new generation of brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects to Chinese patients with ischemic stroke. Leveraging the successful commercialization experience and compliant and efficient operation system, the Group will accelerate the accessibility of innovative therapies to benefit more patients. More Information about Y-3 for Injection The pathological processes of acute ischemic stroke are highly complex and interconnected. There is an urgent clinical need for multi-target, multi-mechanism coordinated interventions to achieve more effective regulation of the complex ischemic cascade, thereby improving treatment outcomes and enhancing patients’ quality of life. Y-3 for Injection is able to uncouple PSD95-nNOS, inhibit MPO activity, and enhance the activity of α2-GABAA receptor (a subtype of GABAA receptor with antidepressant and anxiolytic effects). With this multi-target, highly selective synergistic mechanism, it is expected to achieve a technological breakthrough in the simultaneous intervention of “stroke treatment and prevention of post-stroke depression and anxiety”, making Y-3 for Injection a promising novel brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects. The results of Phase II clinical trial of Y-3 for Injection for the treatment of acute ischemic stroke were presented as an oral poster at the 10th European Stroke Organisation Conference in 2024 (ESOC 2024). It indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (20mg, 40mg, 60mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group (20mg: 67.8% vs 60.7%, 40mg: 76.7% vs 60.7%, 60mg: 70.0% vs 60.7%). Moreover, the Product showed comparable safety to placebo in acute ischemic stroke patients, exhibiting good tolerability. On 24 August 2023, the Group through its wholly-owned subsidiary entered into a Collaboration Agreement (the “Agreement”) with Neurodawn Pharmaceutical Co., Ltd. (“NeuroDawn”), a clinical needs-oriented pharmaceutical company driven by innovation and R&D. In accordance with the Agreement, the Group obtains an exclusive promotion right in mainland China, the Hong Kong Special Administrative Region, and the Macau Special Administrative Region. The term of the Agreement is permanent. About Stroke According to the Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) issued by the National Health Commission, approximately 3.94 million new stroke cases occur in China each year, accounting for one-third of the global new cases[1]. Among these, ischemic stroke accounts for about 72%, with over 2.8 million new cases annually; the number of existing stroke patients in China has exceeded 28 million[1]. Data from China’s cause-of-death monitoring in 2021 shows that stroke-related deaths accounted for 23% of the national total deaths[1]. Over the past three decades, the disease burden of stroke-related disabilities in China has continued to increase[1]. Coupled with factors such as the accelerating aging of the population, the pressure of stroke prevention and control will further intensify in the future, posing enormous challenges to patients’ families and society[1]. In addition, post-stroke depression and anxiety are common complications of stroke, with incidence rates of approximately 30% and 25% respectively[2]. They can hinder the recovery of patients’ neurological functions, even increase the risk of death, and severely affect patients’ prognosis. Y-3 for Injection holds significant potential value for the long-term neurological function improvement and overall prognosis of a vast number of stroke patients, indicating broad market prospects. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference 1. National Health Commission of the People’s Republic of China. Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) [J]. Chinese Journal of Magnetic Resonance Imaging, 2025, 16(1): 1-8. DOI: 10.12015/issn.1674-8034.2025.01.001. 2. Chen Xinyu, Lyu Xiaohan, Li Ruina, et al. Post-Stroke Anxiety [J]. International Journal of Cerebrovascular Disease, 2022, 30(2): 129-133. DOI: 10.3760/cma.j.issn.1673-4165.2022.02.010. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/

CryptoFeeDiscount Launches Free Crypto Trading Fee Calculator for Binance, OKX, Bitget, and 25+ Global Exchanges

New York, NY – December 08, 2025 – (SeaPRwire) – CryptoFeeDiscount, a premier cryptocurrency data aggregation platform, today announced the official launch of its advanced Crypto Trading Fee Savings Calculator. Designed for quant institutions and high-volume traders, this new data-driven engine reveals hidden transaction costs and identifies optimized execution strategies to reduce trading fees by up to 30%. As crypto market volatility increases in late 2025, transaction costs have become a silent profit killer for active traders. A typical futures trader generating $5 to $10 million in monthly volume can lose upwards of $400 to $600 per month in unnecessary maker/taker fees without optimized account structuring. CryptoFeeDiscount addresses this issue by providing a transparent, data-driven interface that allows users to: Compare Real-Time Rates: Instantly visualize the cost difference between top-tier derivatives exchanges like Bitget and Binance. Unlock VIP Fee Discounts for Free: Access exclusive, institutional-grade fee reductions usually reserved for VIP 1-3 levels, bypassing standard trading volume requirements. Verify Promo Codes: Utilize the platform’s database of verified Referral Codes and Promo Codes to ensure maximum sign-up bonuses and lifetime fee rebates. Discover Niche Opportunities: Filter exchanges by specific criteria, such as “Privacy-First” features for secure trading or high-leverage trading options. “Most retail traders obsess over entry and exit prices but completely ignore the frictional cost of trading,” said James Anderson, Lead Analyst at CryptoFeeDiscount. “Our data shows that by simply switching execution venues or applying a verified discount code on platforms like Bitget, a scalper can increase their net profitability by over 15% annually. We built this calculator to make that math visible and actionable.” The platform has already verified and indexed active promo codes for major platforms, ensuring users have access to the lowest possible rates currently available on the market, with savings reaching up to 30% on select crypto exchanges. ABOUT CRYPTOFEEDISCOUNT CryptoFeeDiscount is a leading financial technology website dedicated to transparency in cryptocurrency trading costs. Through its proprietary comparison engine and rigorous verification process, the platform helps traders find the best execution venues, referral codes, and sign-up bonuses. MEDIA CONTACT Brand: CryptoFeeDiscount   Contact: James Anderson Email: team@CryptoFeeDiscount.com Website: https://CryptoFeeDiscount.com

laosidp.com 发布风险提示:仿冒网站 mpwt.ltd 非老挝政府平台,勿用于办理“老挝国际驾照”

Hong Kong - 近期,市场出现利用仿冒网站 mpwt.ltd 进行“老挝国际驾照(IDP)代办”的诈骗行为,导致部分中国游客及境外申请人遭遇无效证件、租车受阻等风险。基于公众安全及信息真实性考量,laosidp.com 发布正式风险提示公告,明确指出该网站并非老挝交通部官方平台。 声明:mpwt.ltd 不属于老挝交通部门 经域名及主机归属核查,网站 mpwt.ltd 为企业性质域名,服务器托管于 中国香港阿里云,与老挝交通公共工程部(Ministry of Public Works and Transport,简称 MPWT)无隶属关系。 laosidp.com 指出:“凡是老挝政府网站,均使用 .gov 级别域名。任何声称可通过 mpwt.ltd 进行驾照真伪查询的机构,均涉嫌误导或欺诈。” 假冒“老挝国际驾照”可能导致严重后果 laosidp.com 同时提醒消费者,不法机构利用 mpwt.ltd 仿冒页面,宣称可以办理“老挝国际驾照 IDP”,并提供所谓“官网查询链接”,已造成多起纠纷与旅行风险: 可能产生的后果包括: 租车机构拒绝接单 保险公司拒绝理赔 交通事故责任无法处理 证件作废或被没收 个人护照信息可能被用于非法用途 laosidp.com 强调:“非法证件不仅无法使用,还可能影响申请人个人信息安全及出入境记录。” 老挝目前不存在公开在线证件查询系统 根据老挝实际行政流程,驾照及 IDP 的真伪核验 只能通过线下渠道,包括: 老挝警署(警务数据库) 老挝交通局(现场备案记录) 官方拍照采集与编号登记 任何宣称“在线查询真伪”的机构,均与老挝官方现行制度不符。 联系方式与公众查询途径 公众如需了解老挝驾驶证政策、法律依据、IDP制度及避险知识,可访问资料网站: Email: support@laosidp.com Website: https://laosidp.com/

老挝IDP假网站(mpwt.ltd)避雷提醒

提醒:真网站mpwt.gov.la,假网站mpwt.ltd 最近有不少人被一个叫 mpwt.ltd 的网站误导,以为是“老挝交通部官网”,还说可以“通过网站查询证件真假”。但事实是:这个网站是伪造网站,不属于老挝政府部门。 下图对比就能看出区别:左边是真官网,右边是假网站 真正的老挝交通运输部官网是:mpwt.gov.la,凡是政府网站,域名都会带 “.gov”(代表政府机构)。 而 “.ltd” 属于普通企业域名,任何个人或公司都能注册。 小白用户在咨询idp 国际驾照时,对方提供的就是这个伪造网址(这个假网站显示服务器位于香港阿里云,不是老挝官方搭建的): 很多用户被假网站误导后,办理假证件可能出现以下几种情况: - 租车时被告知证件无效,行程受阻; - 出现交通事故时,保险公司拒绝理赔; - 个人护照与驾照信息被收集滥用; 证件如何验真: 支持老挝警署验真(可通过本地朋友帮忙代查询),或者要求证件办理后在老挝交通局拍照。 如果还想了解老挝驾照与IDP相关信息,可以访问相关资料网站:laosidp.com(仅供了解使用)

老挝 IDP 诈骗警报:假冒网站 mpwt.ltd 大量骗人,无效“老挝国际驾照”已坑害多人

近期,多名准备办理老挝驾照和老挝 IDP(国际驾照)的中国游客反映,遭遇仿冒的“官方查询网站”——mpwt.ltd。该网站假装为老挝交通部官网,被不良代办机构利用来“证明驾照真伪”,诱导办理假冒国际驾照。 ⚠ 重点提醒:mpwt.ltd 是假网站,不属于老挝政府!真网站:mpwt.gov.la 🔍 真官网 vs 假官网对比 👉 关键判断:真正政府网站必须使用“.gov”域名;“.ltd”仅代表普通公司,不具备官方身份。 🚨 使用假冒老挝 IDP 的风险有多严重? 如果通过 mpwt.ltd 所指示机构办理所谓“老挝国际驾照 / IDP”,可能会面临: 🚫租车公司不认可,无法取车 🚫交通事故保险拒赔 🚫护照信息被非法收集 🚫触犯当地法律,留下不良记录 🚫出入境核验可能被困或遣返 ⚠ 假证不仅不能使用,反而会让旅行更危险! ✔ 正确的老挝驾照 & IDP 验证方式 💡 想确认证件真伪,可通过以下正规渠道: 老挝警署系统:需要本地人或律师代查 老挝交通局办事处现场拍照记录 正规代理必须提供拍照 + 当地备案凭证 证件背面编码可在交通局验证,不通过网站验证 ❗注意:老挝官方目前没有公开在线验证查询系统,任何声称“可以线上查真伪”的都是骗局! 📌 想了解老挝驾照与 IDP?(资料网站) 以下资料仅用于知识查询与科普: 🔗 laosidp.com ※ 本网站不生产证件、不参与办理,仅提供信息对比与避坑知识。 🧭 最后提醒:办理老挝国际驾照不能靠一个网址! 如果某机构说: “我们的网站可以查真伪(mpwt.ltd)” 👉 立刻识别骗局!远离诈骗! 📌 记住三个关键词避坑:mpwt.ltd = 假、老挝 IDP = 需警署备案、国际驾照 ≠ 网上查询